The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia  by Söderström, Maria et al.
The consequences of an outbreak of
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Objective: This retrospective matched case-control study evaluated the consequences of multidrug-resistant Pseudomonas
aeruginosa (MDR Pa) in critical leg ischemia (CLI) patients treated with infrainguinal bypass surgery (IBS).
Methods: An outbreak of MDR Pa occurred on our vascular surgical ward during a 13-month period. Bacteria cultures
positive for MDR Pa were obtained from 129 patients, and 64 CLI patients treated with IBS formed the study group. A
control group of 64 was retrospectively matched from MDR Pa-negative patients treated with IBS in the same unit
according to sex, age, presence of diabetes, Fontaine class, graft material, and site of the distal anastomosis. The most
frequent sites of initial positive MDR Pa culture were the incisional wound in 30 (47%) and ischemic ulcer in 23 (36%).
Median time between the positive MDR Pa-culture and IBS was 14 days (range, 56 days pre-IBS to 246 days post-IBS).
Graft patency, survival, leg salvage, and amputation-free survival were assessed.
Results: One-year amputation-free survival ( standard error) was 52%  6% in the MDR Pa group vs 75%  5% in the
control group (P  .02). Five-year amputation-free survival was 29%  6% in the MDR Pa group and 32%  6% in the
control group (P .144). For MDR Pa and control groups, the 1-year survival was 69% 6% and 82% 5% (P .063),
respectively, and 5-year survival was 36%  6% and 36%  6% (P  .302), respectively. For the MDR Pa and control
groups, leg salvage was 79% 5% and 92% 4% at 1 year (P .078) and 73% 7% and 87% 5% at 5 years (P .126),
respectively. The overall secondary patency rate at 1 year was 72% 7% in the MDR Pa group vs 81% 6% in the control
group (P  .149). Local wound surgery was more frequent in MDR Pa patients than in controls (P  .002).
Conclusions: The MDR Pa outbreak was associated with a decreased short-term amputation-free survival after IBS for
CLI in patients with positive MDR Pa culture. The potential risks of MDR Pa should be seriously considered whenever
a positive culture is obtained in a vascular patient with CLI. (J Vasc Surg 2009;50:806-12.)Pseudomonas aeruginosa (P aeruginosa) is a leading
cause of hospital-acquired infections.1 Patients hospitalized
for a long period are frequently colonized by P aeruginosa
and are at increased risk of developing infection.2 The
prominence of the P aeruginosa pathogen is related to its
ability to develop resistance against almost all antibiotics
and many disinfectants.3,4 The clinical relevance of multi-
drug resistant P aeruginosa (MDR Pa) has been stressed by
reports of nosocomial infections and outbreaks among
critically ill patients and in intensive care units in several
countries.2,5-8
Antimicrobial resistant pathogens are increasingly
involved in vascular surgical site infections.9 Wound and
graft infections are potentially life- and limb-threatening
complications in vascular surgery. The knowledge about
consequences of a MDR Pa outbreak among patients
with critical leg ischemia (CLI) is sparse. The primary
aim of this study was to evaluate amputation-free survival
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806rates after an outbreak of MDR Pa on our vascular
surgical ward among the patients treated with infraingui-
nal bypass surgery (IBS) for CLI. The secondary aim was
to assess graft patency, survival, leg salvage, and reinter-
vention rates.
PATIENTS AND METHODS
The study protocol was approved by the Institutional
Review Board of Helsinki University Central Hospital (De-
partment of Surgery) in 2006.
Definition and description of the MDR Pa-outbreak.
In April 2000, the first positive MDR Pa culture was
obtained and recognized from a patient treated on our
vascular surgical ward in Helsinki University Central Hos-
pital. The strain of P aeruginosa was resistant to ciprofloxa-
cin, tobramycin, and a combination of piperacillin and
tazobactam. As determined from the first 50 samples, the
same P aeruginosa clone caused all but one of the MDR Pa
contaminations.
After the outbreak was recognized, repeated bacterial
specimens were taken from chronic ulcerations and surgical
wounds. Grafts, urine, or blood were cultured as required.
Grouping of the patients according toMDRPa status and the
presence of chronic ulcers was initiated in August 2000. An
infectious diseases consultant evaluated every patient with a
positive MDR Pa result. Patients with signs of MDR Pa
infection, including erythema and swelling around the tissue
lesion, infection of prosthetic material, or positive blood cul-
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MDR Pa-directed microbial therapy was not administered to
patients whose cultures from a superficial site were positive for
MDR Pa but were without signs of infection and asymptom-
atic patients with a positive urine culture.
Eventually in March 2001, positive samples were ob-
tained from biofilms in the showerhead in one of the
washrooms. The same showerhead had been cultured neg-
ative 3 months earlier. The showerhead was replaced, and
the outbreak was controlled within 1month. Between April
2000 and May 2001, 129 patients at our vascular unit
presented with MDR Pa, which represented 15% of the
annual number of in-hospital patients.
Patient evaluation. The study comprised the 64 pa-
tients who had a positive MDR Pa culture and were treated
Table I. Six factors were used for matching 64 patients
infected with multidrug-resistant Pseudomonas aeruginosa
with control patients
Factor
Sex
Age  10 years
Presence of diabetes mellitus
Fontaine class
● III (rest pain), or
● IV(ischemic tissue lesion)
Graft material
● vein, or
● prosthesis
Site of the distal anastomosis
● proximal popliteal artery, or
● distal popliteal artery, or
● crural/pedal artery
Table II. Clinical data of the 64 patients with multidrug-r
Demographics
Age, median (range) 75 (
ABI, median (range) 0.41 (
BMI, median kg/m2 (range) 23 (
Cerebrovascular disease, No. (%) 9 (
Coronary heart disease, No. (%) 34 (
Diabetes mellitus, No. (%) 36 (
Distal anastomosis, No. (%)
Proximal popliteal artery 3 (
Distal popliteal artery 14 (
Crural/pedal artery 47 (
Fontaine class, No. (%)
III 9 (
IV 55 (
Graft material, No. (%)
Vein 56 (
Prosthesis 8 (
Pulmonary disease 12 (
Serum creatinine mg/dL, median (range) 97 (
Sex, No. (%)
Male 35 (
Female 30 (
ABI, Ankle-brachial index; BMI, body mass index.
aIndicates that the patients are matched according to the factor.with IBS for CLI during the outbreak at our vascular ward.
The hospital vascular registry (HUSVasc) data of 517 pa-
tients treated with IBS for CLI between January 2000 and
June 2003 were scrutinized to identify controls for the
MDR Pa-positive patients. A control patient with negative
MDR Pa culture was matched to each study patient accord-
ing to sex, age  10 years, presence of diabetes, Fontaine
class III or IV,10 vein or prosthetic graft material, and site of
the distal anastomosis (proximal popliteal artery, distal
popliteal artery or crural/pedal artery; Table I). The med-
ical records of the cases and controls were re-evaluated in
2008. Survival data were gathered from the Population
Register Centre. Follow-up for this study terminated 5
years after IBS.
Study group demographics. Median age of the 64
patients was 75 years (range, 37-91 years). There were 34
men (53%) and 30 women, and 36 patients (56%) had
diabetes. The indication for the IBS was an ischemic ulcer
(Fontaine IV) in 55 legs (86%). Nine patients had rest pain
(Fontaine III). Median preoperative ankle-brachial index
(ABI) was 0.41 (range, 0.26-2.7). The site of the distal
anastomosis of the infrainguinal bypass was the proximal
popliteal artery in 3 legs (5%), the distal popliteal artery in
14 (22%), and the crural or pedal artery in 48 (73%). Vein
grafts were used in 56 reconstructions (87%), and pros-
thetic grafts were used in 8 (Table II).
P aeruginosa culture. The initial positive MDR Pa
culture was obtained from the incisional wound in 30
patients (47%), from the ischemic ulcer in 23 (36%), from
wounds with undefined location in 10 (16%) and from the
urine in 1 (1%). The MDR Pa culture was positive before
IBS in 10 patients (15%) and after IBS in 55 (85%). Median
time between a positive MDR Pa-culture and IBS was 14
ant Pseudomonas aeruginosa and their controls
Controls P
) 75 (41-91) .947a
2.70) 0.37 (0.21-1.84) .339
) 24 (16-35) .417
8 (13) .795
44 (69) .07
36 (56) .99a
3 (5) .99a
14 (22) .99a
47 (73) .99a
9 (14) .99a
55 (86) .99a
56 (88) .99a
8 (12) .99a
15 (23) .516
6) 96 (53-195) .775
35 (54) .99a
30 (46) .99aesist
Cases
37-91
0.26-
19-44
14)
53)
56)
5)
22)
73)
14)
86)
88)
12)
19)
40-62
54)
46)
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IBS). Intravenous MDR Pa-directed microbial therapy was
used in 43 patients (67%) with signs of MDR Pa-infection.
A drug-sensitive strain of P aeruginosa was cultured from
the ischemic ulcers or incisional wounds in 31 control
patients (48%).
Antimicrobial therapy. In patients with chronic ul-
cers, the antimicrobial treatment was selected according to
the bacterial culture and continued until the wounds had
healed. The corresponding microbial therapy was given
intravenously during surgery. If a patient did not have
chronic ulcers, cefuroxime was administered for surgical
prophylaxis. If a prosthetic graft was used, patients also
received vancomycin for surgical prophylaxis. Patients with
infections caused by MDR Pa were treated with MDR
Pa-directed intravenous microbial therapy at least for 2
weeks, if not contraindicated. A typical regimen was mero-
penem combined with amikacin or ceftazidime.
Statistical analysis. For the statistical analysis, we
used SPSS 16.0 software (SPSS, Chicago, Ill). Differences
between groups were evaluated with the 2 and Mann-
Whitney U test. Kaplan-Meier method was performed for
comparison of variables between patient groups over time
(univariate analysis). Mean data are presented with the
standard error. A value of P  .05 was considered statisti-
cally significant.
RESULTS
Amputation-free survival. The 1-year amputation-
free survival was 52%  6% in the MDR Pa group
compared with 75%  5% in the control group (Fig 1).
Fig 1. Kaplan-Meier curves demonstrate amputation-fr
(MDR Pa) group and in the control group. At 1 year a
decreased amputation-free survival (P  .020; 2 test). A
in both groups (P  .144, Kaplan-Meier analysis). The standThe amputation-free survival was significantly decreased in
patients with MDR Pa at 1 year after IBS compared with
the control group (P  .02, 2 test). The amputation-free
survival rate was 29% 6% at 5 years in the MDR Pa group
and 32%  6% in the control group. Kaplan-Meier analysis
did not show a significant difference between the groups in
the amputation-free survival during the 5-year follow-up
(P  .144).
Survival. The survival was 69%  6% at 1 year and
36%  6% at 5 years in the MDR Pa group compared with
82%  5% and 36%  6% in the control group (Fig 2).
Differences in the survival between the MDR Pa group and
the control group were not significant at 1 year (P  .063,
2 test) or after the 5-year follow-up (P  .302, Kaplan-
Meier analysis).
Leg salvage. The 1-year leg salvage was 79%  5% in
theMDRPa group compared with 92% 4% in the control
group (P .078. 2 test). The leg salvage was 73% 7% at
5 years in the MDR Pa group and 87% 5% in the control
group (P  .126; Kaplan-Meier analysis; Fig 3).
Patency. The 1-year primary patency, assisted-primary
patency, and secondary patency rates were 60%  7%,
67%  7%, and 72%  7% for the MDR Pa group and
64% 8%, 77% 7%, and 81% 6% for the control group
(Fig 4). Univariate analysis and log-rank tests did not show
any significant differences between the MDR Pa and con-
trol group in the primary (P .222) and secondary patency
rates (P  .149), but the assisted-primary patency rate was
worse in the MDR Pa group (P  .049).
Vascular reintervention rates. Vascular reinterven-
tions were required in 17 patients (27%) in the MDR Pa
vival in the multidrug-resistant Pseudomonas aeruginosa
he bypass, patients with MDR Pa showed significantly
5-year follow-up, the amputation-free survival was pooree sur
fter t
fterard error is 10% at each time point in the curve.
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Five of the eight prostheses (63%) were infected by MDR
Pa and were removed. No prosthesis was infected or re-
moved in the control group. The difference between the
Fig 2. Survival rates after infrainguinal bypass surger
Pseudomonas aeruginosa (MDR Pa) group and in the
survival was lower in the MDR Pa group at 1 year comp
statistical significance (P  .063). Both groups showed
standard error is 10% at each time point in the curve.
Fig 3. Kaplan-Meier curves demonstrate the leg salvag
Pseudomonas aeruginosa (MDR Pa) group at 1 year (P 
.126) compared with the control group, but the differen
time point in the curve.number of patients with vascular reinterventions in theMDR Pa group and the control group was not statistically
significant (P  .694).
Local wound surgery. In the MDR Pa group, 40
patients (63%) had local surgery, as did 21 patients (33%) in
e to critical limb ischemia in the multidrug-resistant
ol group demonstrated by Kaplan-Meier analysis. The
ith the control group, but the difference did not reach
survival rates in long-term follow-up (P  .302). The
e leg salvage rate was lower in the multidrug-resistant
8) and at 5 years after infrainguinal bypass surgery (P 
ere not significant. The standard error is 10% at eachy du
contr
ared w
lowe. Th
.07
ces wthe control group (Table III). Significantly more patients in
the c
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control group (P  .002; Table IV).
DISCUSSION
Infrainguinal revascularizations are useless unless life
and limb are preserved. The considerably decreased
amputation-free survival at 1 year in the MDR Pa group
compared with the control group suggests that MDR Pa in
a patient with CLI should always be considered a clinical
challenge for the patient’s outcome. The control patients
were meticulously matched to the MDR Pa patients in our
study. The most vulnerable patients with MDR Pa died
Fig 4. Kaplan-Meier life-table curves demonstrate seco
nosa (MDR Pa) group and in the control group. The di
group and the control group was not significant (P 
infrainguinal bypass surgery, determined by clinical ex
index. The standard error is 10% at each time point in
Table III. Vascular reinterventions performed in the
multidrug-resistant Pseudomonas aeruginosa group and in
the controls
Vascular reintervention Cases no. Controls no.
Number of patients having vascular
re-intervention
17 19
Vascular reinterventions, total 29 28
Distal extension/patch angioplasty 7 8
Suturation 6 3
PTA 1 7
Thrombectomy 3 5
Thrombolysis 3 4
Removal of prosthesis 5 0
Redo bypass 4 1
PTA, Percutaneous transluminal angioplasty.early after IBS or were apt to have a major amputation soonafter the reconstruction due to nonhealing ischemic ulcers
or incisional wounds. Later on during the follow-up, the
differences in the amputation-free survival rates between
the MDR Pa and the control group disappeared. The
explanation behind the lack of influence of the MDR Pa on
long-term follow-up may be that the overall long-term
survival of patients with CLI is low. The survival rate was
36% at 5 years in the control group. Furthermore, owing to
the small number of patients, our studymight lack power to
adequately analyze the differences between subgroups.
Resistance to antimicrobial agents is an increasing pub-
lic health threat.1 To our knowledge, this is the first study
analyzing the consequences of a MDR Pa outbreak among
patients with CLI. Six other case-control studies have asso-
patency in the multidrug-resistant Pseudomonas aerugi-
ce in the secondary patency rate between the MDR Pa
). Graft patency was monitored until 1 year after the
tion, duplex Doppler imaging, and the ankle-brachial
urve.
Table IV. Local wound surgery and major amputations
performed in the multidrug-resistant Pseudomonas
aeruginosa group and in the controls
Wound surgery Cases no. Controls no.
Total patients needing local wound surgery 40 21
Total number of local wound surgery 49 25
Minor amputationa 26 17
Revision 18 5
Skin grafting 3 2
Microvascular flap 2 1
Major amputations 14 8
aTransmetatarsal level or distal to the transmetatarsal level.ndary
fferen
.149
aminaciated MDR Pa with increased death.10 The in-hospital
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tween 21% and 54% in those studies.1,6-8,11 These high
in-hospital mortality rates is be explained by the patient
series, which consisted mostly of patients treated in inten-
sive care units. Multimorbid patients cannot be compared
directly with the patients in our study, although our CLI
patients had several comorbidities. The patient cohort in
our study was unique, because all patients had well-defined
disease and a surgical procedure.
One study did not find any effect of MDR Pa on
death,12 but the bacteria in that study were already consid-
ered MDR if they were resistant to two or more antipseu-
domonal antibiotics. Because there is no international con-
sensus on the definition of MDR in P aeruginosa, the
results in different studies cannot be directly compared.
The site where the MDR Pa is isolated from may
influence short-term mortality. Most of the initial MDR
Pa isolates in this study were from incisional wounds and
ischemic ulcers, whereas the initial MDR Pa in other
studies has frequently been a respiratory isolate.6,7
Bloodstream infection caused by MDR Pa causes consid-
erable death.13
Because in almost half of the control group a non-
MDRPa was cultured from the ischemic ulcers or incisional
wounds, our study indicates that the MDR character of
P aeruginosa has a crucial role for the decreased short-term
rates of amputation-free survival. The initial MDR Pa in-
fection was in the incisional wound in one-third of the
study patients. The incisional wound infection rate has
been reported to be between 2% and 54%, depending on
the type of surgery, patient demographics, and definition of
wound infection.9,14-16 In this study, we did not analyze
wound infection caused by other bacteria. The limited
available means of effectively treating MDR Pa led us to
perform more local wound surgery among the study pa-
tients to eradicate the source of bacteria. Local wound care
could not be analyzed in this retrospective study. The
positive MDR Pa result might have influenced the treat-
ment strategy in some patients.
Although few patients in our study had prosthetic
grafts, we want to stress the poor outcome of these
patients in the MDR Pa group. Five of eight prostheses
were infected in the MDR Pa group; two patients whose
prostheses were removed had a new bypass with vein and
avoided major amputation, whereas the three nonrevas-
cularized patients underwent a major amputation during
the follow-up. No infection of the prosthetic grafts
occurred in the control group. The reported incidence of
vascular prosthetic graft infections varies between 0.2%
and 29%, depending on the location of the graft, indica-
tion for intervention, and host defence mechanisms.9,17
The greatest problem during the outbreak was identi-
fying the source of the MDR Pa. Despite several attempts
to track the origin, it remained obscure. In addition to the
clinical consequences, the outbreak caused additional hos-
pital burden, including cohorting, hygiene control efforts,
bacterial culture sampling, microbial therapy, and increasedhospital length of stay. The economic effect of the outbreak
was not analyzed in this study.
CONCLUSION
MDR Pa was associated with decreased rates of short-
term amputation-free survival in patients treated with IBS
due to CLI compared with a matched cohort of non-MDR
Pa patients. In addition, excess local surgical interventions
for wound treatment and prosthetic graft removals were
required due to MDR Pa. MDR Pa in a patient with CLI
should always be considered as a serious event with high
risk of adverse clinical consequences.
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